Vimarsana
Biggest News Aggregation in the World

Page 27 - Pharmaceutical Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaceutical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaceutical Technology Today - Breaking & Trending Today

EC approves Novartis' Kymriah for follicular lymphoma in adults - Vimarsana News

EC approves Novartis' Kymriah for follicular lymphoma in adults

The EC has granted approval for Novartis’ CAR-T cell therapy, Kymriah, to treat adults with relapsed or refractory follicular lymphoma.

BioMed Momentum: NMLSF, BBI, LMLLF, VERU; Life Sciences - Vimarsana News

BioMed Momentum: NMLSF, BBI, LMLLF, VERU; Life Sciences

NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest...

Access to CAR-T therapies in Central and Eastern Europe in "catch-up" mode - Vimarsana News

Access to CAR-T therapies in Central and Eastern Europe in "catch-up" mode

Although some countries are moving ahead, the use of CAR-T therapies in the region remains uneven.

Next Super Stocks on the Move: NMLSF, NEXCF, OGGFF, MKTDF; - Vimarsana News

Next Super Stocks on the Move: NMLSF, NEXCF, OGGFF, MKTDF;

NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments...

BioMed Stocks On the Move: Nova Mentis, PolarityTE, - Vimarsana News

BioMed Stocks On the Move: Nova Mentis, PolarityTE,

NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest...